# Seres Therapeutics (MCRB) — Earnings

MCRB · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mcrb/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q4 2025 |
| Period end | Dec 31, 2025 |
| EPS actual | −$1.78 |
| EPS estimate | −$2.11 |
| EPS surprise | +15.64% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Mar 12, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1609809/000119312526103034/d98522d8k.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q4 2025 | Mar 12, 2026 | −$2.11 | −$1.78 | 15.64% | — | — |
| Q3 2025 | Nov 5, 2025 | $0.46 | $0.94 | 105.82% | $7.8M | $351,000.00 |
| Q2 2025 | Aug 6, 2025 | −$2.49 | −$2.27 | 8.84% | — | — |
| Q1 2025 | May 7, 2025 | $0.10 | $3.75 | 3576.47% | $10.0M | — |
| Q4 2024 | Mar 13, 2025 | −$3.93 | −$1.80 | 54.20% | — | — |
| Q3 2024 | Nov 13, 2024 | −$1.55 | $11.60 | 848.10% | $31.0M | — |
| Q2 2024 | Aug 13, 2024 | −$5.48 | −$4.40 | 19.73% | — | — |
| Q1 2024 | May 8, 2024 | −$6.83 | −$5.40 | 20.98% | $250,000.00 | — |
| Q4 2023 | Mar 5, 2024 | −$9.93 | −$6.20 | 37.58% | — | $65,000.00 |
| Q3 2023 | Nov 2, 2023 | −$10.03 | −$7.40 | 26.21% | $1.5M | $310,000.00 |
| Q2 2023 | Aug 8, 2023 | $10.69 | $7.20 | -32.64% | $125.7M | $126.5M |
| Q1 2023 | May 9, 2023 | −$11.00 | −$11.40 | -3.64% | $1.6M | — |
| Q4 2022 | Mar 7, 2023 | −$9.10 | −$10.20 | -12.09% | $6.0M | $974,000.00 |
| Q3 2022 | Nov 2, 2022 | −$9.38 | −$9.80 | -4.53% | $7.0M | $3.4M |
| Q2 2022 | Aug 3, 2022 | −$11.93 | −$14.00 | -17.40% | $4.5M | $1.2M |
| Q1 2022 | May 4, 2022 | −$10.48 | −$12.20 | -16.47% | $8.5M | $1.5M |
| Q4 2021 | Mar 1, 2022 | −$8.73 | −$10.40 | -19.08% | $12.3M | $7.2M |
| Q3 2021 | Nov 10, 2021 | −$1.09 | $14.40 | 1422.44% | $28.5M | $126.7M |
| Q2 2021 | Aug 3, 2021 | −$7.40 | −$10.60 | -43.24% | $5.9M | $5.3M |
| Q1 2021 | May 4, 2021 | −$6.20 | −$7.80 | -25.81% | $6.4M | $5.7M |

## Frequently Asked Questions

### When did Seres Therapeutics (MCRB) last report earnings?

Seres Therapeutics last reported on Mar 12, 2026, covering fiscal Q4 2025.

### Did MCRB beat earnings estimates?

Yes. Seres Therapeutics reported EPS of −$1.78 for Q4 2025 against a −$2.11 estimate — a 15.64% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).